Pharmaceutical giant says its vaccine only "may be" effective in reducing "severe disease and hospitalization," and falls short of confirming protection from infection.
In November 2017, the U.S. Environmental Protection Agency announced that MosquitoMate, Inc. had submitted plans to infect live male mosquitoes with a bacteria called "Wolbachia pipientis," which enhances WNV infection.
“We will not shut down our schools. We will not accept your lockdowns. We will not abide by your mask mandates, and we will not tolerate your vaccine mandates.”